0001806356-20-000001.txt : 20200311 0001806356-20-000001.hdr.sgml : 20200311 20200311152801 ACCESSION NUMBER: 0001806356-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200311 DATE AS OF CHANGE: 20200311 EFFECTIVENESS DATE: 20200311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 858 Therapeutics, Inc. CENTRAL INDEX KEY: 0001806356 IRS NUMBER: 834651777 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-362558 FILM NUMBER: 20705147 BUSINESS ADDRESS: STREET 1: 4757 NEXUS CENTER DRIVE STREET 2: SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-987-8380 MAIL ADDRESS: STREET 1: 4757 NEXUS CENTER DRIVE STREET 2: SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001806356 858 Therapeutics, Inc. 4757 NEXUS CENTER DRIVE SUITE 150 SAN DIEGO CA CALIFORNIA 92121 858-987-8380 DELAWARE None None Corporation true 2019 Bradley J. Bolzon c/o 858 Therapeutics, Inc. 4757 Nexus Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Director Clare Ozawa c/o 858 Therapeutics, Inc. 4757 Nexus Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Director James Veal c/o 858 Therapeutics, Inc. 4757 Nexus Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2020-03-03 false true false 0 37500000 20056095 17443905 The total amount sold includes the shares sold upon conversion of an outstanding convertible note. false 1 0 0 0 false 858 Therapeutics, Inc. Jeffrey A. Stafford Jeffrey A. Stafford President and Chief Executive Officer 2020-03-11